Cart
sales@molnova.com
Cancer-Targeting Compound 1
CAS No. 1007581-62-5
Cancer-Targeting Compound 1( —— )
Catalog No. M33205 CAS No. 1007581-62-5
Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 371 | In Stock |
|
| 5MG | 381 | In Stock |
|
| 10MG | 514 | In Stock |
|
| 25MG | 765 | In Stock |
|
| 50MG | 1004 | In Stock |
|
| 100MG | 1349 | In Stock |
|
| 200MG | 1814 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCancer-Targeting Compound 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.
-
DescriptionCancer-Targeting Compound 1 is used in the research of hormone- related cancer, extracted from patent WO 2008021331 A2.
-
In VitroCancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1007581-62-5
-
Formula Weight299.35
-
Molecular FormulaC15H13N3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)COC(=O)N1c1nc(cs1)-c1ccc(cc1)C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.
molnova catalog
related products
-
(+)-ORM-10921
(+)-ORM-10921 is a conformation of ORM-10921 and can be used in chemical synthesis studies.
-
BGB 15025
HPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseases.
-
R(+)-Gomisin M1
Gomisin M1 ((±)-Gomisin M1) is a potent anti-HIV agent with an EC50 of <0.65 μM.
